HIV-1 entry and entry inhibitors as therapeutic agents
- 1 September 2002
- journal article
- review article
- Published by Elsevier in Clinics In Laboratory Medicine
- Vol. 22 (3) , 681-701
- https://doi.org/10.1016/s0272-2712(02)00011-2
Abstract
No abstract availableKeywords
This publication has 115 references indexed in Scilit:
- Inhibition of HIV-1 infection by down-regulation of the CXCR4 co-receptor using an intracellular single chain variable fragment against CXCR4Gene Therapy, 2001
- Downregulation of the CCR5 β-Chemokine Receptor and Inhibition of HIV-1 Infection by Stable VA1-Ribozyme Chimeric TranscriptsAntisense and Nucleic Acid Drug Development, 2000
- Function of the chemokine receptor CXCR4 in haematopoiesis and in cerebellar developmentNature, 1998
- The chemokine receptor CXCR4 is essential for vascularization of the gastrointestinal tractNature, 1998
- Inhibition of T-tropic HIV Strains by Selective Antagonization of the Chemokine Receptor CXCR4The Journal of Experimental Medicine, 1997
- The β-Chemokine Receptors CCR3 and CCR5 Facilitate Infection by Primary HIV-1 IsolatesPublished by Elsevier ,1996
- A Dual-Tropic Primary HIV-1 Isolate That Uses Fusin and the β-Chemokine Receptors CKR-5, CKR-3, and CKR-2b as Fusion CofactorsCell, 1996
- Mutational analysis of the interaction between CD4 and class II MHC: Class II antigens contact CD4 on a surface opposite the gp120-binding siteCell, 1991
- Crystal structure of an HIV-binding recombinant fragment of human CD4Nature, 1990
- HIV-1 tropism for mononuclear phagocytes can be determined by regions of gp120 outside the CD4-binding domainNature, 1990